In contrast, ME2 silencing significantly decreased the number of AML cells in shME2-MV4-11 mice by monitoring CD33 + and CD45 + cells in the peripheral blood (Fig. 3D and E). This evidence concerns the gene PTPRC and acute myeloid leukemia.